Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 902
Filter
1.
Nutrients ; 16(9)2024 Apr 25.
Article in English | MEDLINE | ID: mdl-38732526

ABSTRACT

Distillers' grains are rich in protein and constitute a high-quality source of various bioactive peptides. The purpose of this study is to identify novel bioactive peptides with α-glucosidase inhibitory, antioxidant, and insulin resistance-ameliorating effects from distiller's grains protein hydrolysate. Three novel peptides (YPLPR, AFEPLR, and NDPF) showed good potential bioactivities, and the YPLPR peptide had the strongest bioactivities, whose IC50 values towards α-glucosidase inhibition, radical scavenging rates of 2,2'-azino-bis (3-ethylbenzothiazoline-6- sulfonic acid) (ABTS) and 2,2-diphenyl-1-picrylhydrazyl (DPPH) were about 5.31 mmol/L, 6.05 mmol/L, and 7.94 mmol/L, respectively. The glucose consumption of HepG2 cells treated with YPLPR increased significantly under insulin resistance condition. Moreover, the YPLPR peptide also had a good scavenging effect on intracellular reactive oxygen species (ROS) induced by H2O2 (the relative contents: 102.35% vs. 100%). Molecular docking results showed that these peptides could stably combine with α-glucosidase, ABTS, and DPPH free radicals, as well as related targets of the insulin signaling pathway through hydrogen bonding and van der Waals forces. This research presents a potentially valuable natural resource for reducing oxidative stress damage and regulating blood glucose in diabetes, thereby increasing the usage of distillers' grains peptides and boosting their economic worth.


Subject(s)
Antioxidants , Glycoside Hydrolase Inhibitors , Insulin Resistance , Molecular Docking Simulation , Peptides , Glycoside Hydrolase Inhibitors/pharmacology , Hep G2 Cells , Humans , Antioxidants/pharmacology , Peptides/pharmacology , Peptides/chemistry , Edible Grain , alpha-Glucosidases/metabolism , Protein Hydrolysates/pharmacology , Reactive Oxygen Species/metabolism , Hypoglycemic Agents/pharmacology , Computer Simulation , Insulin , Sulfonic Acids , Biphenyl Compounds , Picrates , Benzothiazoles
2.
Int J Mol Sci ; 25(9)2024 Apr 25.
Article in English | MEDLINE | ID: mdl-38731887

ABSTRACT

This study explores olive flounder by-product Prozyme2000P (OFBP) hydrolysate as a potential treatment for age-related kidney decline. Ferroptosis, a form of cell death linked to iron overload and oxidative stress, is increasingly implicated in aging kidneys. We investigated whether OFBP could inhibit ferroptosis and improve kidney health. Using TCMK-1 cells, we found that OFBP treatment protected cells from ferroptosis induced by sodium iodate (SI). OFBP also preserved the mitochondria health and influenced molecules involved in ferroptosis regulation. In aging mice, oral administration of OFBP significantly improved kidney health markers. Microscopic examination revealed reduced thickening and scarring in the kidney's filtering units, a hallmark of aging. These findings suggest that OFBP hydrolysate may be a promising therapeutic candidate for age-related kidney decline. By inhibiting ferroptosis, OFBP treatment appears to improve both cellular and structural markers of kidney health. Further research is needed to understand how OFBP works fully and test its effectiveness in more complex models.


Subject(s)
Ferroptosis , Kidney , Animals , Ferroptosis/drug effects , Mice , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Aging/drug effects , Flounder/metabolism , Oxidative Stress/drug effects , Protein Hydrolysates/pharmacology , Protein Hydrolysates/chemistry , Mitochondria/drug effects , Mitochondria/metabolism , Male , Cell Line , Kidney Diseases/drug therapy , Kidney Diseases/metabolism , Kidney Diseases/pathology
3.
Physiol Plant ; 176(3): e14357, 2024.
Article in English | MEDLINE | ID: mdl-38775128

ABSTRACT

The application of protein hydrolysates (PH) biostimulants is considered a promising approach to promote crop growth and resilience against abiotic stresses. Nevertheless, PHs bioactivity depends on both the raw material used for their preparation and the molecular fraction applied. The present research aimed at investigating the molecular mechanisms triggered by applying a PH and its fractions on plants subjected to nitrogen limitations. To this objective, an integrated transcriptomic-metabolomic approach was used to assess lettuce plants grown under different nitrogen levels and treated with either the commercial PH Vegamin® or its molecular fractions PH1(>10 kDa), PH2 (1-10 kDa) and PH3 (<1 kDa). Regardless of nitrogen provision, biostimulant application enhanced lettuce biomass, likely through a hormone-like activity. This was confirmed by the modulation of genes involved in auxin and cytokinin synthesis, mirrored by an increase in the metabolic levels of these hormones. Consistently, PH and PH3 upregulated genes involved in cell wall growth and plasticity. Furthermore, the accumulation of specific metabolites suggested the activation of a multifaceted antioxidant machinery. Notwithstanding, the modulation of stress-response transcription factors and genes involved in detoxification processes was observed. The coordinated action of these molecular entities might underpin the increased resilience of lettuce plants against nitrogen-limiting conditions. In conclusion, integrating omics techniques allowed the elucidation of mechanistic aspects underlying PH bioactivity in crops. Most importantly, the comparison of PH with its fraction PH3 showed that, except for a few peculiarities, the effects induced were equivalent, suggesting that the highest bioactivity was ascribable to the lightest molecular fraction.


Subject(s)
Lactuca , Nitrogen , Protein Hydrolysates , Lactuca/metabolism , Lactuca/genetics , Lactuca/drug effects , Lactuca/growth & development , Nitrogen/metabolism , Protein Hydrolysates/metabolism , Protein Hydrolysates/pharmacology , Gene Expression Regulation, Plant/drug effects , Metabolomics , Plant Growth Regulators/metabolism , Transcriptome/genetics , Multiomics
4.
Food Funct ; 15(10): 5566-5578, 2024 May 20.
Article in English | MEDLINE | ID: mdl-38712886

ABSTRACT

Free radical damage and oxidative stress are thought to play a crucial role in the development of neurodegenerative diseases. Walnut peptides, especially walnut oligopeptides, have been shown to protect nerve cells from oxidative stress and inflammatory damage, as well as improve memory function. In this study, walnut peptides were obtained from walnut meal through enzymatic hydrolysis, ultrafiltration, and gel filtration chromatography. A novel oligopeptide called AQ was successfully isolated and its chemical structure was identified as AASCDQ using ESI-MS/MS. AQ demonstrated remarkable scavenging activity against O2- free radicals (81.00%), DPPH free radicals (79.40%), and ABTS free radicals (67.09%) at a concentration of 1 mg mL-1. Furthermore, AQ exhibited strong neuroprotective effects against hydrogen peroxide-induced damage in SH-SY5Y cells, reducing cell injury and apoptosis. AQ also effectively inhibited the secretion of pro-inflammatory factors NO (IC50 = 46.03 ± 0.32 µM) and suppressed the expression of IL-6 and TNF-α in RAW264.7 cells stimulated by LPS. In vivo experiments demonstrated that AQ promoted angiogenesis in the quail chick chorioallantoic membrane assay and reduced ROS accumulation in Caenorhabditis elegans, thereby extending its lifespan. The anti-inflammatory mechanism of AQ was further confirmed by western blotting. In summary, the novel oligopeptide AQ possesses potential neuroprotective effects, including antioxidant, anti-inflammatory, angiogenic, and anti-aging properties, making it a promising candidate for the development of functional foods and pharmaceutical products.


Subject(s)
Caenorhabditis elegans , Juglans , Neuroprotective Agents , Oligopeptides , Animals , Juglans/chemistry , Neuroprotective Agents/pharmacology , Neuroprotective Agents/chemistry , Mice , Caenorhabditis elegans/drug effects , RAW 264.7 Cells , Humans , Oligopeptides/pharmacology , Oligopeptides/chemistry , Oxidative Stress/drug effects , Apoptosis/drug effects , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/chemistry , Protein Hydrolysates/pharmacology , Protein Hydrolysates/chemistry , Reactive Oxygen Species/metabolism , Nuts/chemistry , Antioxidants/pharmacology , Antioxidants/chemistry
5.
Ter Arkh ; 96(3): 266-272, 2024 Apr 16.
Article in Russian | MEDLINE | ID: mdl-38713042

ABSTRACT

AIM: To investigate the antitumor effects of human placenta hydrolysate (HPH) peptides on three hormone-dependent human cell lines: prostate adenocarcinoma, breast carcinoma, and ovarian cancer by metabolic analysis of cell cultures. MATERIALS AND METHODS: The effect of HPH on tumor and control tumor cell lines was evaluated. Study stages: (A) de novo peptide sequencing by collision-induced dissociation mass spectrometry; (B) detection of peptides with anti-tumor properties; (C) expert analysis of the obtained lists of peptides. RESULTS: Dose-dependent cytotoxic effects of HPH on three tumor cell lines are shown: PC-3 (human prostate adenocarcinomas), OAW-42 (human ovarian cancer), BT-474 (human breast carcinomas), and IC50 constants (1.3-2.8 mg/ml) were obtained. The analysis of the HPH peptide fraction showed more than 70 peptides with antitumor properties in the composition of this HPH, including kinase inhibitors: mitogen-activated protein kinases, kappa-bi nuclear factor inhibitor kinase, AKT serine/threonine kinase 1, protein kinase C zeta, interleukin-1 receptor-associated kinase 4 and cyclin-dependent kinase 1. CONCLUSION: The results of the study indicate not only the oncological safety of the HPH used in therapy but also the mild antitumor effects of this HPH at high concentrations.


Subject(s)
Breast Neoplasms , Placenta , Prostatic Neoplasms , Humans , Female , Placenta/metabolism , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Pregnancy , Prostatic Neoplasms/drug therapy , Male , Cell Line, Tumor , Antineoplastic Agents/pharmacology , Ovarian Neoplasms/drug therapy , PC-3 Cells , Protein Hydrolysates/pharmacology , Dose-Response Relationship, Drug
6.
Food Funct ; 15(10): 5315-5328, 2024 May 20.
Article in English | MEDLINE | ID: mdl-38605685

ABSTRACT

In this study, walnut protein was hydrolyzed, separated by ultrafiltration, purified by RP-HPLC, identified by LC-MS/MS, and screened by molecular docking to finally obtain three novel antioxidant peptides HGEPGQQQR (1189.584 Da), VAPFPEVFGK (1089.586 Da) and HNVADPQR (949.473 Da). These three peptides exhibited excellent cellular antioxidant activity (CAA) with EC50 values of 0.0120 mg mL-1, 0.0068 mg mL-1, and 0.0069 mg mL-1, respectively, which were superior to that of the positive control GSH (EC50: 0.0122 mg mL-1). In the ethanol injury model, three antioxidant peptides enhanced the survival of cells treated with ethanol from 47.36% to 62.69%, 57.06% and 71.64%, respectively. Molecular docking results showed that the three antioxidant peptides could effectively bind to Keap1, CYP2E1 and TLR4 proteins. These results suggested that walnut-derived antioxidant peptides could be potential antioxidants and hepatoprotective agents for application in functional foods.


Subject(s)
Antioxidants , Juglans , Molecular Docking Simulation , Peptides , Protein Hydrolysates , Juglans/chemistry , Antioxidants/pharmacology , Antioxidants/chemistry , Peptides/pharmacology , Peptides/chemistry , Protein Hydrolysates/pharmacology , Protein Hydrolysates/chemistry , Humans , Kelch-Like ECH-Associated Protein 1/metabolism , Plant Proteins/pharmacology , Plant Proteins/chemistry , Ethanol , Toll-Like Receptor 4/metabolism , Cytochrome P-450 CYP2E1/metabolism , Protective Agents/pharmacology , Protective Agents/chemistry , Nuts/chemistry , Tandem Mass Spectrometry
7.
Mar Drugs ; 22(4)2024 Mar 28.
Article in English | MEDLINE | ID: mdl-38667768

ABSTRACT

Metabolic disorders are increasingly prevalent conditions that manifest pathophysiologically along a continuum. Among reported metabolic risk factors, elevated fasting serum glucose (FSG) levels have shown the most substantial increase in risk exposure. Ultimately leading to insulin resistance (IR), this condition is associated with notable deteriorations in the prognostic outlook for major diseases, including neurodegenerative diseases, cancer risk, and mortality related to cardiovascular disease. Tackling metabolic dysfunction, with a focus on prevention, is a critically important aspect for human health. In this study, an investigation into the potential antidiabetic properties of a salmon protein hydrolysate (SPH) was conducted, focusing on its potential dipeptidyl peptidase-IV (DPP-IV) inhibition and direct glucose uptake in vitro. Characterization of the SPH utilized a bioassay-guided fractionation approach to identify potent glucoregulatory peptide fractions. Low-molecular-weight (MW) fractions prepared by membrane filtration (MWCO = 3 kDa) showed significant DPP-IV inhibition (IC50 = 1.01 ± 0.12 mg/mL) and glucose uptake in vitro (p ≤ 0.0001 at 1 mg/mL). Further fractionation of the lowest MW fractions (<3 kDa) derived from the permeate resulted in three peptide subfractions. The subfraction with the lowest molecular weight demonstrated the most significant glucose uptake activity (p ≤ 0.0001), maintaining its potency even at a dilution of 1:500 (p ≤ 0.01).


Subject(s)
Dipeptidyl-Peptidase IV Inhibitors , Glucose , Protein Hydrolysates , Salmo salar , Animals , Dipeptidyl-Peptidase IV Inhibitors/pharmacology , Dipeptidyl-Peptidase IV Inhibitors/isolation & purification , Dipeptidyl-Peptidase IV Inhibitors/chemistry , Protein Hydrolysates/pharmacology , Protein Hydrolysates/chemistry , Glucose/metabolism , Humans , Dipeptidyl Peptidase 4/metabolism , Hypoglycemic Agents/pharmacology , Hypoglycemic Agents/chemistry , Fish Proteins/pharmacology
8.
Mar Drugs ; 22(4)2024 Mar 28.
Article in English | MEDLINE | ID: mdl-38667773

ABSTRACT

The industrial processing of Argentine shortfin squid to obtain rings generates a significant amount of protein-rich waste, including the skin, which is rich in collagen and attached myofibrillar proteins. This waste is generally discarded. In this study, skin was used as a source of proteins that were hydrolysed using Trypsin, Esperase® or Alcalase®, which released peptides with antioxidant potential and, in particular, antihypertensive (ACE inhibition), hypoglycemic (DPP-IV inhibition) and/or nootropic (PEP inhibition) potential. Among the three enzymes tested, Esperase® and Alcalase produced hydrolysates with potent ACE-, DPP-IV- and PEP-inhibiting properties. These hydrolysates underwent chromatography fractionation, and the composition of the most bioactive fractions was analysed using HPLC-MS-MS. The fractions with the highest bioactivity exhibited very low IC50 values (16 and 66 µg/mL for ACE inhibition, 97 µg/mL for DPP-IV inhibition and 55 µg/mL for PEP inhibition) and were mainly derived from the hydrolysate obtained using Esperase®. The presence of Leu at the C-terminal appeared to be crucial for the ACE inhibitory activity of these fractions. The DPP-IV inhibitory activity of peptides seemed to be determined by the presence of Pro or Ala in the second position from the N-terminus, and Gly and/or Pro in the last C-terminal positions. Similarly, the presence of Pro in the peptides present in the best PEP inhibitory fraction seemed to be important in the inhibitory effect. These results demonstrate that the skin of the Argentine shortfin squid is a valuable source of bioactive peptides, suitable for incorporation into human nutrition as nutraceuticals and food supplements.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors , Decapodiformes , Dipeptidyl-Peptidase IV Inhibitors , Peptides , Animals , Decapodiformes/chemistry , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Angiotensin-Converting Enzyme Inhibitors/chemistry , Angiotensin-Converting Enzyme Inhibitors/isolation & purification , Peptides/chemistry , Peptides/pharmacology , Dipeptidyl-Peptidase IV Inhibitors/pharmacology , Dipeptidyl-Peptidase IV Inhibitors/chemistry , Hydrolysis , Protein Hydrolysates/chemistry , Protein Hydrolysates/pharmacology , Dipeptidyl Peptidase 4/chemistry , Dipeptidyl Peptidase 4/metabolism , Skin , Tandem Mass Spectrometry , Chromatography, High Pressure Liquid , Antioxidants/pharmacology , Antioxidants/chemistry
9.
J Agric Food Chem ; 72(17): 10076-10088, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38629202

ABSTRACT

This study aimed to explore antioxidant peptides derived from sturgeon (Acipenser schrenckii) ovaries that exhibit antiosteoporotic effects in oxidative-induced MC3T3-E1 cells. The F3-15 component obtained from sturgeon ovarian protein hydrolysates (SOPHs) via gel filtration and RP-HPLC significantly increased the cell survival rate (from 49.38 ± 2.88 to 76.26 ± 2.09%). Two putative antioxidant-acting peptides, FDWDRL (FL6) and FEGPPFKF (FF8), were screened from the F3-15 faction via liquid chromatography-tandem mass spectrometry (LC-MS/MS) and through prediction by computer simulations. Molecular docking results indicated that the possible antioxidant mechanisms of FL6 and FF8 involved blocking the active site of human myeloperoxidase (hMPO). The in vitro tests showed that FL6 and FF8 were equally adept at reducing intracellular ROS levels, increasing the activity of antioxidant enzymes, and protecting cells from oxidative injuries by inhibiting the mitogen-activated protein kinase (MAPK) pathway and activating the phosphoinositide-3 kinase (PI3K)/protein kinase B (AKT)/glycogen synthase kinase-3ß (GSK-3ß) signaling pathway. Moreover, both peptides could increase differentiation and mineralization abilities in oxidatively damaged MC3T3-E1 cells. Furthermore, FF8 exhibited high resistance to pepsin and trypsin, showcasing potential for practical applications.


Subject(s)
Fish Proteins , Fishes , Osteoblasts , Ovary , Oxidative Stress , Peptides , Protein Hydrolysates , Animals , Protein Hydrolysates/chemistry , Protein Hydrolysates/pharmacology , Oxidative Stress/drug effects , Female , Mice , Osteoblasts/drug effects , Osteoblasts/metabolism , Osteoblasts/cytology , Peptides/chemistry , Peptides/pharmacology , Peptides/isolation & purification , Fish Proteins/chemistry , Fish Proteins/pharmacology , Fish Proteins/metabolism , Ovary/drug effects , Ovary/metabolism , Antioxidants/chemistry , Antioxidants/pharmacology , Cell Line , Cell Survival/drug effects , Molecular Docking Simulation , Reactive Oxygen Species/metabolism , Humans , Phosphatidylinositol 3-Kinases/metabolism , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol 3-Kinases/chemistry , Glycogen Synthase Kinase 3 beta/metabolism , Glycogen Synthase Kinase 3 beta/genetics , Tandem Mass Spectrometry
10.
Mar Biotechnol (NY) ; 26(2): 404-420, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38558367

ABSTRACT

Optimization of antioxidants and angiotensin-converting enzyme (ACE) inhibitory potential gelatin hydrolysate production from Labeo rohita (rohu) swim bladder (SBGH) by alcalase using central composite design (CCD) of response surface methodology (RSM) was investigated. The maximum degree of hydrolysis (DH), 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2'-azino-bis-3-ethylbenzthiazoline-6-sulphonic acid (ABTS), total antioxidants (TAO), and ACE inhibitory activity were achieved at 0.1:1.0 (w/w) enzyme to substrate ratio, 61 °C hydrolysis temperature, and 94-min hydrolysis time. The resulting SBGH obtained at 19.92% DH exhibited the DPPH (24.28 µM TE/mg protein), ABTS (34.47 µM TE/mg protein), TAO (12.01 µg AAE/mg protein), and ACE inhibitory (4.91 µg/mg protein) activity. Furthermore, SBGH at 100 µg/ml displayed osteogenic property without any toxic effects on MC3T3-E1 cells. Besides, the protein content of rohu swim bladder gelatin (SBG) and SBGH was 93.68% and 94.98%, respectively. Both SBG and SBGH were rich in glycine, proline, glutamic acid, alanine, arginine, and hydroxyproline amino acids. Therefore, SBGH could be an effective nutraceutical in functional food development.


Subject(s)
Air Sacs , Fishes , Animals , Air Sacs/chemistry , Air Sacs/metabolism , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Angiotensin-Converting Enzyme Inhibitors/chemistry , Antioxidants/pharmacology , Antioxidants/chemistry , Biphenyl Compounds/chemistry , Cyprinidae/metabolism , Fish Proteins/metabolism , Gelatin/chemistry , Hydrolysis , Osteogenesis/drug effects , Picrates , Protein Hydrolysates/chemistry , Protein Hydrolysates/pharmacology , Subtilisins/metabolism , Fishes/metabolism
11.
Pak J Biol Sci ; 27(3): 152-159, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38686737

ABSTRACT

<b>Background and Objective:</b> Rabbit meat is a livestock product potentially viable as a protein source to obtain peptides. Antioxidant and antimicrobial peptides are ingredients extracted from various foods through enzymatic hydrolysis, chemical hydrolysis and fermentation to produce health-promoting foods. This research aims to investigate the potential of rabbit meat as a source of antioxidant and antimicrobial peptides through hydrolysis using trypsin and zingibain enzymes. <b>Materials and Methods:</b> This research conducted an explorative-descriptive approach, focusing on antioxidant and antimicrobial activity. Rabbit meat was extracted using trypsin, zingibain and a combination of trypsin and crude extract zingibain. The hydrolyzed rabbit meat extract was tested at intervals of 0, 2, 6, 16, 24, 40 and 48 hrs to determine the degree of hydrolysis and the profile of hydrolyzed proteins with electrophoresis SDS PAGE. The antioxidant activity was tested using the DPPH method and the antimicrobial activity using agar well diffusion method. <b>Results:</b> The degree of hydrolysis increased with the hydrolysis time. The highest protein content of rabbit meat extract hydrolyzed with trypsin was 287.65 mg/mL, observed during 12 hrs hydrolysis. The optimum conditions for the hydrolysis of rabbit meat protein were obtained at 24 hrs, with an IC<sub>50</sub> value of 52.45% hydrolyzed by trypsin. As per antimicrobial activities, <i>Escherichia coli</i> and <i>Salmonella</i> sp. were more effective in inhibiting rabbit meat hydrolysates compared to <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i>. The inhibition of all pathogen increased until 12 hrs hydrolysis but decreased in 24 hrs hydrolysis. <b>Conclusion:</b> The combination zingibain enzyme and trypsin is feasible for hydrolyzing rabbit meat and the optimum hydrolysis time was 24 hrs with IC<sub>50</sub> 52.45 ppm, although accompanied by reduction in antibacterial activities.


Subject(s)
Antioxidants , Meat , Trypsin , Animals , Rabbits , Antioxidants/pharmacology , Trypsin/metabolism , Hydrolysis , Protein Hydrolysates/pharmacology , Anti-Infective Agents/pharmacology , Antimicrobial Peptides/pharmacology , Antimicrobial Peptides/chemistry , Peptides/pharmacology , Peptides/chemistry , Microbial Sensitivity Tests , Anti-Bacterial Agents/pharmacology
12.
Food Chem ; 446: 138763, 2024 Jul 15.
Article in English | MEDLINE | ID: mdl-38428077

ABSTRACT

Calcium deficiency is prone to fractures, osteoporosis and other symptoms. In this study, sheep bone protein hydrolysates (SBPHs) were obtained by protease hydrolysis. A low-calcium-diet-induced calcium-deficiency rat model was established to investigate the effects of SBPHs on calcium absorption and intestinal flora composition. The results showed that an SBPHs + CaCl2 treatment significantly increased the bone calcium content, bone mineral density, trabecular bone volume, and trabecular thickness, and reduced trabecular separation, and changed the level of bone turnover markers (P < 0.05). Supplementation of SBPHs + CaCl2 can remarkably enhance the bone mechanical strength, and the microstructure of bone was improved, and the trabecular network was more continuous, complete, and thicker. Additionally, SBPHs + CaCl2 dietary increased the abundance of Firmicutes and reduced the abundance of Proteobacteria and Verrucomicrobiota, and promoted the production of short chain fatty acids. This study indicated that SBPHs promoted calcium absorption and could be applied to alleviate osteoporosis.


Subject(s)
Calcium , Osteoporosis , Rats , Animals , Sheep , Calcium/metabolism , Protein Hydrolysates/pharmacology , Calcium Chloride/pharmacology , Calcium, Dietary , Bone Density , Osteoporosis/metabolism , Diet
13.
Food Funct ; 15(7): 3722-3730, 2024 Apr 02.
Article in English | MEDLINE | ID: mdl-38489157

ABSTRACT

Bioactive peptides have been considered potential components for the future functional foods and nutraceuticals generation. The enzymatic method of hydrolysis has several advantages compared to those of chemical hydrolysis and fermentation. Despite this fact, the high cost of natural and commercial proteases limits the commercialization of hydrolysates in the food and pharmacological industries. For this reason, more efficient and economically interesting techniques, such as the immobilisation of the enzyme, are gaining attention. In the present study, a new protein hydrolysate from Lupinus angustifolius was generated by enzymatic hydrolysis through the immobilisation of the enzyme alcalase® (imLPH). After the chemical and nutritional characterization of the imLPH, an in vivo study was carried out in order to evaluate the effect of 12 weeks treatment with imLPH on the plasmatic lipid profile and antioxidant status in western-diet-fed apolipoprotein E knockout mice. The immobilisation of alcalase® generated an imLPH with a degree of hydrolysis of 29.71 ± 2.11%. The imLPH was mainly composed of protein (82.50 ± 0.88%) with a high content of glycine/glutamine, arginine, and aspartic acid/asparagine. The imLPH-treatment reduced the amount of abdominal white adipose tissue, total plasma cholesterol, LDL-C, and triglycerides, as well as the cardiovascular risk indexes (CRI) -I, CRI-II, and atherogenic index of plasma. The imLPH-treated mice also showed an increase in the plasma antioxidant capacity. For the first time, this study demonstrates the beneficial in vivo effect of a lupin protein hydrolysate obtained with the alcalase® immobilised and points out this approach as a possible cost-effective solution at the expensive generation of the hydrolysate through the traditional batch conditions with soluble enzymes.


Subject(s)
Lupinus , Protein Hydrolysates , Animals , Mice , Protein Hydrolysates/pharmacology , Protein Hydrolysates/chemistry , Antioxidants/chemistry , Lupinus/metabolism , Subtilisins/metabolism , Endopeptidases/metabolism , Hydrolysis
14.
Food Chem ; 447: 138873, 2024 Jul 30.
Article in English | MEDLINE | ID: mdl-38452536

ABSTRACT

Food-derived angiotensin-converting enzyme-inhibitory (ACE-I) peptides have attracted extensive attention. Herein, the ACE-I peptides from Scomber japonicus muscle hydrolysates were screened, and their mechanisms of action and inhibition stability were explored. The quantitative structure-activity relationship (QSAR) model based on 5z-scale metrics was developed to rapidly screen for ACE-I peptides. Two novel potential ACE-I peptides (LTPFT, PLITT) were predicted through this model coupled with in silico screening, of which PLITT had the highest activity (IC50: 48.73 ± 7.59 µM). PLITT inhibited ACE activity with a mixture of non-competitive and competitive mechanisms, and this inhibition mainly contributed to the hydrogen bonding based on molecular docking study. PLITT is stable under high temperatures, pH, glucose, and NaCl. The zinc ions (Zn2+) and copper ions (Cu2+) enhanced ACE-I activity. The study suggests that the QSAR model is effective in rapidly screening for ACE-I inhibitors, and PLITT can be supplemented in foods to lower blood pressure.


Subject(s)
Protein Hydrolysates , Quantitative Structure-Activity Relationship , Molecular Docking Simulation , Protein Hydrolysates/pharmacology , Protein Hydrolysates/chemistry , Peptides/pharmacology , Peptides/chemistry , Muscles/metabolism , Ions , Angiotensins , Peptidyl-Dipeptidase A/metabolism
15.
J Anim Sci ; 1022024 Jan 03.
Article in English | MEDLINE | ID: mdl-38442226

ABSTRACT

Research on protein hydrolysates has observed various properties and functionalities on ingredients depending on the type of hydrolysate. The objective of this study was to evaluate the effects of hydrolyzed chicken protein that was incorporated into diets on digestibility, gut health, skin and coat health, oxidative stress, and intestinal inflammation markers in healthy adult dogs. Five complete and balanced diets were manufactured: (1) CONd: 25% chicken meal diet; (2) 5% CLHd: 5% chicken liver and heart hydrolysate plus 20% chicken meal diet; (3) CLHd: 25% chicken liver and heart hydrolysate diet; (4) 5% CHd: 5% chicken hydrolysate plus 20% chicken meal diet; (5) CHd: 25% chicken hydrolysate diet. A replicated 5 × 5 Latin square design was used which included 10 neutered adult Beagles. Each of the 5 periods consisted of a 7-d washout time and a 28-d treatment period. All diets were well accepted by the dogs. Fecal butyrate concentration was higher while fecal isovalerate and total phenol/indole were lower in dogs fed CLHd than CONd (P < 0.05). Dogs fed CHd had higher fecal immunoglobulin A concentration when compared with CLHd (P < 0.05); however, both groups were comparable to the CONd. There was no difference among groups in serum cytokine concentrations, serum oxidative stress biomarkers, or skin and coat health analyses (P > 0.05). Fecal microbiota was shifted by CLHd with higher abundance in Ruminococcus gauvreauii group as well as lower Clostridium sensu stricto 1, Sutterella, Fusobacterium, and Bacteroides when compared with CONd (P < 0.05). There was also a difference in beta diversity of fecal microbiota between CLHd and CHd (P < 0.05). In conclusion, chicken protein hydrolysate could be incorporated into canine extruded diets as a comparable source of protein to traditional chicken meal. The test chicken protein hydrolysates showed the potential to support gut health by modulating immune response and microbiota; however, functional properties of protein hydrolysates are dependent on inclusion level and source.


Research has been exploring various functional properties of hydrolyzed protein to benefit the health of animals. However, the functionality of a hydrolyzed protein depends on the type of hydrolysate. Therefore, this study was conducted to evaluate the effect of hydrolysates from chicken meat and hydrolysates from chicken heart and liver on digestibility, gut health, skin and coat health, oxidative stress, and inflammation in healthy adult dogs. Five canine diets were manufactured with similar ingredients except for the test protein sources. The control diet was formulated with chicken meal, a traditional protein source in pet food, and the other diets had a partial or complete substitution from the chicken meal with the two types of protein hydrolysate. The diets were all well accepted by the dogs and all dogs maintained healthy throughout the study. Dogs fed the hydrolysate from chicken meat showed lower inflammatory biomarkers in the feces. On the other hand, dogs fed the hydrolysate from chicken liver and heart demonstrated a shift in gut microbiota with more abundant beneficial bacteria. In conclusion, poultry-originated protein hydrolysates showed the potential in making positive changes in inflammatory state, immune response, and microbiota in healthy adult dogs.


Subject(s)
Microbiota , Protein Hydrolysates , Dogs , Animals , Protein Hydrolysates/pharmacology , Digestion , Feces/microbiology , Nutrients/metabolism , Diet/veterinary , Chickens , Animal Feed/analysis
16.
Article in English | MEDLINE | ID: mdl-38430604

ABSTRACT

Typically, bioactive peptides were uncovered from complex hydrolysates using sequential bioassay-guided fractionation. To increase the efficiency of bioactive peptide screening, a simple and convenient tandem bioassay-guided fractionation based on solid-phase extraction (SPE) was conducted to screen the angiotensin-I-converting enzyme (ACE) inhibitory peptides from the hydrolysate of Inca nut cake protein (INCP). The so-called SCX-RP SPE system was constructed by assembling SCX (strong cation exchange) and RP (reversed phase) SPE cartridges. Using this tandem SCX-RP SPE, the INCP digested with combined gastrointestinal protease (INCP GP) was fractionated into 30 fractions. The fraction F11 exhibited the highest ACE inhibitory activity among 30 fractions. The ACE IC50 of fraction F11 was calculated to be 6.6 ± 0.5 µg/mL. The ACEI activity of fraction F11 was stronger than the INCP GP hydrolysate (ACE IC50 of 12.7 ± 0.4 µg/mL). The tandem SCX-RP SPE fractionation reduced the number of ACE inhibitory (ACEI) peptide candidates from 127 peptides in the INCP GP hydrolysate to only ten peptides in fraction F11. Subsequently, WALPTQSW (WW-8) and WLPTKSW (WW-7) from fraction F11 were synthesized, and their ACE IC50 was determined to be 4.7 ± 0.1 and 7.9 ± 0.1 µM, respectively. The dipeptidyl peptidase-4 (DPP4) inhibitory and 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging activities of WALPTQSW (WW-8) were also explored to give IC50 values of 131.7 ± 5.2 and 191.8 ± 7.0 µM, respectively. The molecular docking and inhibition mechanism studies indicated that WW-8 inhibited ACE and DPP4 as competitive and non-competitive inhibitors, respectively. The pre-incubation experiment of WW-8 toward ACE and DPP4 demonstrated that WW-8 was a true-inhibitor type. Additionally, the amount of WW-8 was quantified to be 5.8 ± 0.2 and 35 ± 0.4 µg per milligram hydrolysate and fraction F11, respectively. This study demonstrated tandem bioassay-guided SCX-RP SPE fractionation efficiently screened ACEI peptide derived from INCP GP hydrolysate, adding more value to Inca nut cake (a leftover of the oil industry) as a bioactive peptide precursor.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors , Protein Hydrolysates , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Protein Hydrolysates/pharmacology , Dipeptidyl Peptidase 4 , Nuts , Molecular Docking Simulation , Peptides/pharmacology , Solid Phase Extraction , Peptidyl-Dipeptidase A
17.
Int J Biol Macromol ; 266(Pt 2): 131126, 2024 May.
Article in English | MEDLINE | ID: mdl-38527682

ABSTRACT

The objective of this study was to explore the potential of Antarctic krill-derived peptides as α-glucosidase inhibitors for the treatment of type 2 diabetes. The enzymolysis conditions of α-glucosidase inhibitory peptides were optimized by response surface methodology (RSM), a statistical method that efficiently determines optimal conditions with a limited number of experiments. Gel chromatography and LC-MS/MS techniques were utilized to determine the molecular weight (Mw) distribution and sequences of the hydrolysates. The identification and analysis of the mechanism behind α-glucosidase inhibitory peptides were conducted through conventional and computer-assisted techniques. The binding affinities between peptides and α-glucosidase were further validated using BLI (biolayer interferometry) assay. The results revealed that hydrolysates generated by neutrase exhibited the highest α-glucosidase inhibition rate. Optimal conditions for hydrolysis were determined to be an enzyme concentration of 6 × 103 U/g, hydrolysis time of 5.4 h, and hydrolysis temperature of 45 °C. Four peptides (LPFQR, PSFD, PSFDF, VPFPR) with strong binding affinities to the active site of α-glucosidase, primarily through hydrogen bonding and hydrophobic interactions. This study highlights the prospective utility of Antarctic krill-derived peptides in curtailing α-glucosidase activity, offering a theoretical foundation for the development of novel α-glucosidase inhibitors and related functional foods to enhance diabetes management.


Subject(s)
Euphausiacea , Glycoside Hydrolase Inhibitors , Peptides , alpha-Glucosidases , Euphausiacea/chemistry , Animals , Glycoside Hydrolase Inhibitors/pharmacology , Glycoside Hydrolase Inhibitors/chemistry , Peptides/chemistry , Peptides/pharmacology , Peptides/isolation & purification , alpha-Glucosidases/metabolism , alpha-Glucosidases/chemistry , Hydrolysis , Protein Hydrolysates/chemistry , Protein Hydrolysates/pharmacology , Powders , Antarctic Regions , Amino Acid Sequence , Molecular Weight
18.
Int J Biol Macromol ; 266(Pt 2): 131152, 2024 May.
Article in English | MEDLINE | ID: mdl-38556230

ABSTRACT

This study aims to seek angiotensin-I-converting enzyme inhibitory (ACEi) peptides from walnut using different enzymatic hydrolysis, and further to validate the potent ACEi peptides identified and screened via peptidomics and in silico analysis against hypertension in spontaneously hypertensive rats (SHRs). Results showed that walnut protein hydrolysate (WPH) prepared by combination of alcalase and simulated gastrointestinal digestion exhibited high ACEi activity. WPH was separated via Sephadex-G25, and four peptides were identified, screened and verified based on their PeptideRanker score, structural characteristic and ACE inhibition. Interestingly, FDWLR showed the highest ACEi activity with IC50 value of 8.02 µg/mL, which might be related to its close affinity with ACE observed in molecular docking. Subsequently, high absorption and non-toxicity of FDWLR was predicted via in silico absorption, distribution, metabolism, excretion and toxicity. Furthermore, FDWLR exhibited positively vasoregulation in Ang II-induced human umbilical vein endothelial cells, and great blood pressure lowering effect in SHRs.


Subject(s)
Angiotensin II , Angiotensin-Converting Enzyme Inhibitors , Human Umbilical Vein Endothelial Cells , Hypertension , Juglans , Molecular Docking Simulation , Protein Hydrolysates , Rats, Inbred SHR , Juglans/chemistry , Animals , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Angiotensin-Converting Enzyme Inhibitors/chemistry , Humans , Human Umbilical Vein Endothelial Cells/drug effects , Protein Hydrolysates/pharmacology , Protein Hydrolysates/chemistry , Rats , Hypertension/drug therapy , Hypertension/metabolism , Angiotensin II/metabolism , Peptides/chemistry , Peptides/pharmacology , Male , Peptidyl-Dipeptidase A/metabolism , Antihypertensive Agents/pharmacology , Antihypertensive Agents/chemistry , Blood Pressure/drug effects , Plant Proteins/pharmacology , Plant Proteins/chemistry
19.
Neurochem Res ; 49(6): 1603-1615, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38353895

ABSTRACT

We aimed to investigate whether the consumption of Egg White Hydrolysate (EWH) acts on nervous system disorders induced by exposure to Cadmium (Cd) in rats. Male Wistar rats were divided into (a) Control (Ct): H2O by gavage for 28 days + H2O (i.p. - 15th - 28th day); (b) Cadmium (Cd): H2O by gavage + CdCl2 - 1 mg/kg/day (i.p. - 15th - 28th day); (c) EWH 14d: EWH 1 g/kg/day by gavage for 14 days + H2O (i.p.- 15th - 28th day); (d) Cd + EWH cotreatment (Cd + EWHco): CdCl2 + EWH for 14 days; (e) EWH 28d: EWH for 28 days; (f) EWHpre + Cd: EWH (1st - 28th day) + CdCl2 (15th - 28th day). At the beginning and the end of treatment, neuromotor performance (Neurological Deficit Scale); motor function (Rota-Rod test); ability to move and explore (Open Field test); thermal sensitivity (Hot Plate test); and state of anxiety (Elevated Maze test) were tested. The antioxidant status in the cerebral cortex and the striatum were biochemically analyzed. Cd induces anxiety, and neuromotor, and thermal sensitivity deficits. EWH consumption prevented anxiety, neuromotor deficits, and alterations in thermal sensitivity, avoiding neuromotor deficits both when the administration was performed before or during Cd exposure. Both modes of administration reduced the levels of reactive species, and the lipid peroxidation increased by Cd and improved the striatum's antioxidant capacity. Pretreatment proved to be beneficial in preventing the reduction of SOD activity in the cortex. EWH could be used as a functional food with antioxidant properties capable of preventing neurological damage induced by Cd.


Subject(s)
Cadmium , Egg White , Oxidative Stress , Rats, Wistar , Animals , Male , Oxidative Stress/drug effects , Cadmium/toxicity , Egg White/chemistry , Rats , Antioxidants/pharmacology , Antioxidants/therapeutic use , Nervous System Diseases/chemically induced , Nervous System Diseases/prevention & control , Nervous System Diseases/drug therapy , Protein Hydrolysates/pharmacology , Protein Hydrolysates/therapeutic use , Neuroprotective Agents/therapeutic use , Neuroprotective Agents/pharmacology
20.
J Food Sci ; 89(4): 2482-2493, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38369943

ABSTRACT

The calcium-binding capacity and osteoblast proliferation and differentiation were studied in Alaska pollock surimi hydrolysate (APSH) using a system that mimics the gastrointestinal digestive system. Evaluation of the calcium absorption-promoting ability of APSH revealed that the best calcium-binding ability was achieved after hydrolysis with a combination of pepsin, α-chymotrypsin, and trypsin, and separation into <3 kDa (APSH-I), 3-5 kDa (APSH-II), 5-10 kDa (APSH-III), and <10 kDa (APSH-IV) fractions. Scanning electron microscopy with energy-dispersive X-ray spectroscopy analysis confirmed that the hydrolysate and calcium ions formed a complex. Comparison of the calcium absorption capacity using Caco-2 cells showed that calcium absorption was promoted by these hydrolysates. Measurement of the osteoblast activation revealed higher alkaline phosphatase activity, collagen synthesis, and mineralization effect for the low-molecular-weight hydrolysate (LMH) than for the other hydrolysates. In addition, LMH promoted the expression of osteocalcin, osteopontin, and bone morphogenetic protein-2 and -4, which are hormones related to bone formation. Expression of the Runx2 transcription factor, which regulates the expression of these hormones, also increased. These results suggest that Alaska pollock surimi protein hydrolysates prepared using a system that mimics gastrointestinal hydrolysis may result in better osteoblast proliferation and bone health than those prepared using other proteases.


Subject(s)
Calcium , Osteogenesis , Humans , Calcium/metabolism , Protein Hydrolysates/pharmacology , Protein Hydrolysates/metabolism , Caco-2 Cells , Alaska , Cell Differentiation , Osteoblasts/metabolism , Calcium, Dietary/metabolism , Hormones/metabolism , Core Binding Factor Alpha 1 Subunit/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...